Nexus AG: STRONG SALES AND EARNINGS INCREASE IN THE FIRST HALF-YEAR 2024

[ Report ]

Donaueschingen (pta009/13.08.2024/09:31) - 13. August 2024: Nexus AG, one of the leading European suppliers of software solutions in the healthcare sector, was able to increase its sales by approx. 14% and EBIT by approx. 18% in the first six months of 2024. As a result, the continually

positive development of sales and earnings of the last years could be continued.

Sales improved from KEUR 111,842 to KEUR 127,665 (+14.2%) in the first half-year 2024. The international share of total business volume was 44.1% (6M-2023: 47.9%) and amounted to KEUR 56,233 compared to KEUR 53,516 (6M-2023).

The consolidated earnings before taxes (EBT) increased by 15.0% to KEUR 16,935 (6M-2023: KEUR 14,729), and consolidated surplus rose by 15.4% to KEUR 12,382 (6M-2023: 10,734 KEUR). EBIT rose very sharply by 18.2% from KEUR 13,888 (6M-2023) to KEUR 16,410, and EBITDA increased by 14.2% to KEUR 25,44 (6M-2023: KEUR 22,276). Operating cash increased by 8.5% to KEUR 27,611 in the first six months (6M-2023: KEUR 25,460).

As of 30/06/2024, the company had cash resources at its disposal in the amount of KEUR 108,034 (31/12/2023: KEUR 97,434).

Excluding the companies acquired in the second half of 2023, the increase in sales would have been 9.4% and the increase in EBIT would have been 20.9%. KEUR 1,508 was spent on the integration of the acquired companies in the first half of 2024, which was recognised in earnings.

Nexus AG had equity capital amounting to KEUR 262,210 as of 30/06/2024 (31/12/2023: KEUR 258,582). Consequently, the equity capital rate is 61.9% (31/12/2023: 62.8%). This demonstrates that Nexus AG has a sustainable and healthy balance sheet as well as sufficient capital for further financing of its European growth strategy.

Donaueschingen, 13. August 2024

The Managing Board

(Ende)